Metraipolis › archive › dc_290ebf5fb50d
Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel — Europe PMC PMID:38374060
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38374060
- DOI
- 10.1186/s13584-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T01:32:43.616Z
- SHA-256 of the archived text
6e480773f37f11f73a40aa28e88947733040c7adb6a768286fced81ee4f14f0f- Stable URL of this page
https://metraipolis.com/documento/dc_290ebf5fb50d
How to cite
Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel — Europe PMC PMID:38374060 — Europe PMC (en), https://europepmc.org/article/MED/38374060 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_290ebf5fb50d (Metraipolis archive dc_290ebf5fb50d, sha256 6e480773f37f11f73a40aa28e88947733040c7adb6a768286fced81ee4f14f0f)
BibTeX
@misc{dc290ebf5fb50d,
title = {Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel — Europe PMC PMID:38374060},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38374060},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_290ebf5fb50d; sha256 6e480773f37f11f73a40aa28e88947733040c7adb6a768286fced81ee4f14f0f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38374060. Agents can read the archived copy with the MCP tool read_document.